Mumbai-based Aakaar Medical Technologies Ltd, a prominent player in the cosmetic dermatology and medical aesthetics space, has announced the launch of its SME Initial Public Offering (IPO) on NSE Emerge. Under the dynamic leadership of Founder & Managing Director Mr. Dilip Meswani and CEO Dr. Rahul Sawakhande, the company has built a strong foundation, combining over three decades of industry expertise. This experience has translated into a robust portfolio of more than 150 SKUs, comprising in-house developed brands as well as exclusive international collaborations with globally recognized partners such as Innoaesthetics (Spain), Theraderm (South Korea), Croma-Pharma (Austria), and Medytox (South Korea).
Operating exclusively through B2B channels, Aakaar Medical Technologies caters to dermatologists, plastic surgeons, and aesthetic physicians across India. The company’s offerings include a diverse range of cosmetic dermatology products and medical devices, sourced both domestically and through imports from countries known for cutting-edge aesthetic solutions including South Korea, Spain, Italy, and Austria. Aesthetic products form the core of Aakaar's business and contribute a significant portion of its revenue. The company has built its market presence on strong doctor-led demand, a nationwide distribution network, and a training-driven engagement model that emphasizes continuous professional education and product proficiency for its clients.
The upcoming IPO will open for subscription on June 20, 2025. Aakaar Medical Technologies Ltd aims to raise up to ₹27 crore at the upper price band through the issuance of 37,50,400 equity shares with a face value of ₹10 each. The shares will be listed on NSE Emerge, the SME platform of the National Stock Exchange. The IPO proceeds are expected to support the company’s growth plans, strengthen its balance sheet, and fund expansion initiatives as it seeks to further solidify its position in India’s rapidly growing aesthetic and cosmetic dermatology market.
With a combination of strategic global partnerships, deep industry experience, and a focused doctor-driven approach, Aakaar Medical Technologies Ltd is poised to capitalize on the increasing demand for aesthetic medical solutions in India.